AAAAAA

   
Results: 1-8 |
Results: 8
POSSIBLE EFFECTIVENESS OF CLARITHROMYCIN AND RIFABUTIN FOR CRYPTOSPORIDIOSIS CHEMOPROPHYLAXIS IN HIV DISEASE
Authors: HOLMBERG SD MOORMAN AC VONBARGEN J PALELLA FJ LOVELESS MO WARD DJ NAVIN TR
Citation: Sd. Holmberg et al., POSSIBLE EFFECTIVENESS OF CLARITHROMYCIN AND RIFABUTIN FOR CRYPTOSPORIDIOSIS CHEMOPROPHYLAXIS IN HIV DISEASE, JAMA, the journal of the American Medical Association, 279(5), 1998, pp. 384-386
RISK-FACTORS FOR PRIMARY PNEUMOCYSTIS-CARINII PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADOLESCENTS AND ADULTS IN THE UNITED-STATES - REASSESSMENT OF INDICATIONS FOR CHEMOPROPHYLAXIS
Authors: KAPLAN JE HANSON DL NAVIN TR JONES JL
Citation: Je. Kaplan et al., RISK-FACTORS FOR PRIMARY PNEUMOCYSTIS-CARINII PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADOLESCENTS AND ADULTS IN THE UNITED-STATES - REASSESSMENT OF INDICATIONS FOR CHEMOPROPHYLAXIS, The Journal of infectious diseases, 178(4), 1998, pp. 1126-1132
DETECTING CRYPTOSPORIDIOSIS AS A CAUSE OF DIARRHEAL ILLNESS - IMPLICATIONS FOR CLINICIAN
Authors: NAVIN TR
Citation: Tr. Navin, DETECTING CRYPTOSPORIDIOSIS AS A CAUSE OF DIARRHEAL ILLNESS - IMPLICATIONS FOR CLINICIAN, JAMA, the journal of the American Medical Association, 277(17), 1997, pp. 1355-1356
MOLECULAR EPIDEMIOLOGY OF PNEUMOCYSTIS-CARINII PNEUMONIA
Authors: BEARD CB NAVIN TR
Citation: Cb. Beard et Tr. Navin, MOLECULAR EPIDEMIOLOGY OF PNEUMOCYSTIS-CARINII PNEUMONIA, EMERGING INFECTIOUS DISEASES, 2(2), 1996, pp. 147-150
TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PERSONS - RISK-FACTORS AND TRENDS
Authors: JONES JL HANSON DL CHU SY CIESIELSKI CA KAPLAN JE WARD JW NAVIN TR
Citation: Jl. Jones et al., TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PERSONS - RISK-FACTORS AND TRENDS, AIDS, 10(12), 1996, pp. 1393-1399
USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INTRODUCTION/
Authors: KAPLAN JE MASUR H HOLMES KK MCNEIL MM SCHONBERGER LB NAVIN TR HANSON DL GROSS PA JAFFE HW LANIER D SCHRAM N COOPER E FREEDBERG KA MAYER K BLINKHORN R ELLNER J ANGULO F BERKELMAN R BREIMAN R BRYAN R BUEHLER J CLADWELL B CASTRO K CHILDS JE CHU S CIESIELSKI C DROTMAN DP EDLIN B ELLERBROCK T FLEMING P GEITER L HAJJEH R HANSON D HOLMBERG S HUGHES J JAFFE H JONES J JURANEK D KAPLAN JE KELLER D MARTONE W MILLER B NAVIN T NESLUND V OSTROFF S PELLETT PE PINNER R REEF S REEVES WC REGNERY R RICHARDS F ROGERS M SIMONDS RJ SIMONE P SMITH D SOLOMON S SPIEGEL R STEWART J SWERDLOW D VERNON S WARD J NEAL J SCHLECH W WILFERT C HORSBURGH R MCGOWAN J RIMLAND D GOLDBERGER M TRAPNELL CB BARR D TORRES G STETLER H GROSS P ELSADAR W COTTON D GREAVES W BARTLETT J CHAISSON R FEINBERG J QUINN T HORMAN J MACDONALD K WILSON M SPERLING R AVANDANO A BAKER AC KALICA A KOVACS J POLIS M SCHNITTMAN S NELSON C PHAIR J BENSON C WOOD B HUGHES W LUFT B HYSLOP N WHITLEY R AMPEL N DREW WL KOEHLER J WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INTRODUCTION/, Clinical infectious diseases, 21, 1995, pp. 1-11
PREVENTING PNEUMOCYSTIS-CARINII PNEUMONIA IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: SIMONDS RJ HUGHES WT FEINBERG J NAVIN TR
Citation: Rj. Simonds et al., PREVENTING PNEUMOCYSTIS-CARINII PNEUMONIA IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 44-48
EFFICACY OF A SHORT-COURSE (10 DAYS) OF HIGH-DOSE MEGLUMINE ANTIMONATE WITH OR WITHOUT INTERFERON-GAMMA IN TREATING CUTANEOUS LEISHMANIASISIN GUATEMALA
Authors: ARANA BA NAVIN TR ARANA FE BERMAN JD ROSENKAIMER F
Citation: Ba. Arana et al., EFFICACY OF A SHORT-COURSE (10 DAYS) OF HIGH-DOSE MEGLUMINE ANTIMONATE WITH OR WITHOUT INTERFERON-GAMMA IN TREATING CUTANEOUS LEISHMANIASISIN GUATEMALA, Clinical infectious diseases, 18(3), 1994, pp. 381-384
Risultati: 1-8 |